-
1
Mayor Isko has enough antibodies vs severe COVID-19 after 2nd dose of CoronaVac
Опубликовано в: Manila Bulletin (2021)Статья -
2
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 2 biopharmaceutical characterization: the NISTmAb case study
Опубликовано 2015Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
3
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 3 defining the next generation of analytical and biophysical techniques
Опубликовано 2015Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
4
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization
Опубликовано 2014Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
5
Bispecific antibodies
Опубликовано в: Springer ebooks. (2011)Available for University of the Philippines Diliman via SpringerLink. Click here to access
Electronic Resource -
6
Antibody expression and production
Опубликовано в: Springer eBooks. (2011)Available for University of the Philippines Diliman via SpringerLink. Click here to access
Electronic Resource -
7
-
8
Generation of single-chain variable antibody fragments (scFv) against dengue virus by phage display
Опубликовано 2002Диссертация -
9
-
10